Kamada Q1 FY26 net income rises 4% to USD 4.1 million; revenue increases 3% to USD 45.2 million

Kamada

Kamada

KMDA

0.00
  • Kamada posted Q1 2026 net income of USD 4.13 million, up 4% year over year, with revenue rising 3% to USD 45.24 million.
  • Adjusted EBITDA was USD 11.6 million, unchanged from prior year, with adjusted EBITDA margin at 26% of revenue.
  • Gross margin narrowed 5 percentage points to 42%.
  • Results reflected a temporary shipment delay of a single order, later delivered in April, with management citing rising underlying demand for KEDRAB in US market and KAMRAB and VARIZIG in ex-US markets.
  • 2026 guidance reaffirmed for revenue of USD 200 million-USD 205 million, adjusted EBITDA of USD 50 million-USD 53 million; FDA cleared Kamada Plasma collection center in San Antonio to start commercial sales of normal source plasma.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kamada Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605130700PRIMZONEFULLFEED9719338) on May 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.